AQR Capital Management’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-761
Closed -$76K 2316
2021
Q2
$76K Sell
761
-5,883
-89% -$607K ﹤0.01% 2197
2021
Q1
$848K Buy
6,644
+2,799
+73% +$414K ﹤0.01% 1625
2020
Q4
$427K Buy
+3,845
New +$431K ﹤0.01% 1839
2016
Q3
Sell
-145
Closed -$121K 2285
2016
Q2
$121K Hold
145
﹤0.01% 2154
2016
Q1
$120K Sell
145
-60
-29% -$47.1K ﹤0.01% 2173
2015
Q4
$231K Sell
205
-53
-21% -$61.7K ﹤0.01% 2105
2015
Q3
$219K Buy
+258
New +$374K ﹤0.01% 2028
2014
Q4
Sell
-596
Closed -$599K 2610
2014
Q3
$599K Buy
596
+8
+1% +$9.04K ﹤0.01% 1874
2014
Q2
$776K Hold
588
﹤0.01% 1771
2014
Q1
$819K Buy
588
+321
+120% +$417K ﹤0.01% 1785
2013
Q4
$306K Buy
+267
New +$368K ﹤0.01% 2288

Other funds holding RMTI

AQR Capital Management's RMTI Position: Q3 2021 in Review

AQR Capital Management sold out of Rockwell Medical (RMTI) in Q3 2021, closing a stake of 761 shares — an estimated $76K sold.

AQR Capital Management first reported a position in RMTI in Q4 2013 and held it in 11 quarters. The position peaked at $848K in Q1 2021. 62 funds tracked by Wall St. Rank hold RMTI as of Q3 2021.

  • AQR Capital Management reported no remaining Rockwell Medical position as of Q3 2021 after selling out during the quarter.
  • AQR Capital Management sold 761 Rockwell Medical shares in Q3 2021, an estimated $76K.
  • AQR Capital Management first reported a position in Rockwell Medical in Q4 2013 and held it in 11 quarters.
  • AQR Capital Management's Rockwell Medical position peaked at $848K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2021.

Based on AQR Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.